We are live on ! Find out more
DERM

Dermira, Inc.
DERM

Delisted

DERM was delisted on the 19th of February, 2020.

126 hedge funds and large institutions have $1.1B invested in Dermira, Inc. in 2017 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 47 increasing their positions, 39 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 39

16% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 19

2% more funds holding

Funds holding: 123126 (+3)

2% less capital invested

Capital invested by funds: $1.12B → $1.1B (-$19M)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

40% less call options, than puts

Call options by funds: $8.44M | Put options by funds: $14.1M

Holders
126
Holders Change
+3
Holders Change %
+2.44%
% of All Funds
2.86%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
22
Increased
47
Reduced
39
Closed
19
Calls
$8.44M
Puts
$14.1M
Net Calls
-$5.7M
Net Calls Change
-$4.4M
Name Holding Trade Value Shares
Change
Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$9.07M +$402K +15,163 +5%
Axa
27
Axa
France
$8.44M +$83.3K +3,141 +1%
TCM
28
Tekla Capital Management
Massachusetts
$7.47M -$3.4M -128,400 -32%
Bank of America
29
Bank of America
North Carolina
$7.39M -$22.9K -865 -0.3%
GC
30
Guggenheim Capital
Illinois
$6.31M -$670K -25,253 -10%
JP Morgan Chase
31
JP Morgan Chase
New York
$6.22M -$174K -6,578 -3%
Alyeska Investment Group
32
Alyeska Investment Group
Illinois
$5.59M -$3.98M -150,000 -43%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$5.54M +$208K +7,847 +4%
Charles Schwab
34
Charles Schwab
California
$5.01M +$802K +30,244 +20%
CCP
35
Clough Capital Partners
Massachusetts
$4.92M -$963K -36,300 -17%
Goldman Sachs
36
Goldman Sachs
New York
$4.66M -$176K -6,620 -4%
CWG
37
C WorldWide Group
Denmark
$3.92M -$318K -11,999 -8%
Dimensional Fund Advisors
38
Dimensional Fund Advisors
Texas
$3.87M +$642K +24,228 +21%
EAM
39
Eventide Asset Management
Massachusetts
$3.45M
AllianceBernstein
40
AllianceBernstein
Tennessee
$3.08M +$212K +8,000 +8%
IBT
41
International Biotechnology Trust
United Kingdom
$3M
PAMU
42
Pictet Asset Management (UK)
United Kingdom
$2.88M +$538K +20,300 +24%
Renaissance Technologies
43
Renaissance Technologies
New York
$2.8M +$98.1K +3,700 +4%
Ameriprise
44
Ameriprise
Minnesota
$2.79M +$23.6K +891 +0.9%
AIC
45
AWM Investment Company
New York
$2.79M +$676K +25,500 +34%
IHM
46
Iguana Healthcare Management
New York
$2.78M -$663K -25,000 -20%
GTC
47
Ghost Tree Capital
New York
$2.78M +$2.65M +100,000 New
OM
48
Opaleye Management
Massachusetts
$2.78M +$2.65M +100,000 New
TCIM
49
TIAA CREF Investment Management
New York
$2.65M -$154K -5,807 -6%
RPAM
50
Rhenman & Partners Asset Management
Sweden
$2.64M -$133K -5,000 -5%

DERM Hedge Fund Activity: Q4 2017 in Review

126 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Dermira, Inc. (DERM) for Q4 2017, worth a combined $1.1B — down 1.7% from $1.12B a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new DERM positions and 19 closed out — a net gain of 3 holders — while 47 added to existing stakes and 39 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $23.9M. The largest seller was TimesSquare Capital Management, exiting entirely with an estimated $61.5M sold.

  • 126 institutional investors held Dermira, Inc. (DERM) as of Q4 2017, up from 123 in Q3 2017.
  • Funds reported $1.1B of Dermira, Inc. stock for Q4 2017, down 1.7% quarter-over-quarter.
  • 22 funds opened new Dermira, Inc. positions in Q4 2017 and 19 closed out, a net change of +3 holders.
  • The largest Dermira, Inc. buyer in Q4 2017 was Millennium Management, an estimated $23.9M added.
  • The largest Dermira, Inc. seller in Q4 2017 was TimesSquare Capital Management, an estimated $61.5M sold.

Based on aggregated 13F filings for Q4 2017.